42
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Late relapse of extranodal natural killer/T cell lymphoma, nasal type, after more than ten years

, , , , , , & show all
Pages 171-173 | Received 28 Aug 2009, Accepted 12 Oct 2009, Published online: 04 Nov 2009

References

  • Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol 2008;26:66–72.
  • Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 2007;139:532–544.
  • Swerdlow SH, Campo E, Harris NL, et al WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.
  • Au WY, Weisenburger DD, Intragumtornchai T, et al Clinical differences between nasal and extranasal NK/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project. Blood 2009;113:3931–3937.
  • Lee J, Au WY, Park MJ, et al Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008;14:1356–1364.
  • Yamaguchi M, Suzuki R, Kwong YL, et al Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016–1020.
  • Chim CS, Ooi GC, Shek TW, et al Lethal midline granuloma revisited: nasal T/natural-killer cell lymphoma. J Clin Oncol 1999;17:1322–1325.
  • Schrader C, Janssen D, Kneba M, Lennert K. A 38-year history of natural-killer-cell lymphoma. N Engl J Med 2004;350:418–419.
  • Lee J, Suh C, Park YH, et al Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612–618.
  • Chim CS, Ma SY, Au WY, et al Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004;103:216–221.
  • Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008. Ann Oncol 2009;20:1472–1482.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.